スズキ アツシ   Suzuki Atsushi
  鈴木 敦
   所属   医学部 医学科(東京女子医科大学病院)
   職種   講師
言語種別 英語
発表タイトル Outcome of Severe Ischemic Heart Failure Patients Treated with Amiodarone
会議名 The 21st Annual Scientific Meeting of the Japanese Heart Failure Society
主催者 Japanese Heart Failure Society
学会区分 全国規模の学会
発表形式 ポスター掲示
講演区分 一般
発表者・共同発表者◎SUZUKI Atsushi, SHIGA Tsuyoshi, ARAI Kotaro, HAGIWARA Nobuhisa
発表年月日 2017/10/13
開催地
(都市, 国名)
Akita, JAPAN
概要 Severe heart failure patients with reduced left ventricular ejection fraction (LVEF) still have poor outcomes. The outcome of amiodarone treatment for severe ischemic HF patients is still unknown. We studied 65 patients (67 ± 12 years old, 54 men) with severe HF (New York Heart Association [NYHA] functional class 3 or 4) due to ischemic heart disease treated by amiodarone. During 24 months of follow-up, 44 patients (81%) were died (Fig. 1). 89% of patients were treated with beta-blockers and/or angiotensinconverting-enzyme inhibitors or angiotensin-receptor blockers. After amiodarone treatment, NYHA functional class was significantly improved, and heart rate was significantly decreased than before (Table 1). However, LVEF was not improved. Alternative treatment for severe heart failure patients is needed.